Brought to you by 
Start-up Zogenix grosses $60mm with Series A; adds $18mm
11 Jan 2008
Executive Summary
Zogenix (neurological diseases) raised $60mm in its Series A round that was co-led by Clarus Ventures and Domain Associates and included BA Venture Partners, Thomas, McNerney & Partners, and Life Science Angels. Members from each VC firm will take a seat on the company's board.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Start-up Zogenix grosses $60mm with Series A; adds $18mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice